Revealed: Sir Patrick Vallance has £600,000 shareholding in firm contracted to develop vaccines
www.telegraph.co.uk | September 23, 2020
The UK’s chief scientific adviser has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, prompting claims of a potential conflict of interest….
From photo caption:
Sir Patrick Vallance, the chief scientific adviser, has already cashed in more than £5 million worth of shares he received from GSK during his tenure from 2012 until March 2018